No perhaps in the scheme of it, isn't much. Having said that, there haven't been many opportunities to sell above breakeven. I wonder if the other major seller has got their nose out of joint for not receiving the raising? My point is, I have no doubt that in this tough market, there will be plenty of advisors that will take the quick profit for a win to themselves and the client. We haven't done the second tranche either. So, what do you think is going to happen when the scoping study comes out assuming it is good? There is going to be no shortage of sellers from the advisors or clients. Advisors work off brokerage and clients trading and will move to the next one (it would be naive to think otherwise). Everyone is assuming it will give the green light to go to next step (obviously it will). What is the next catalyst after that?? You'll go blue in the face waiting for the rail route to be done (look at sdl). Having said that, I still believe 4c is a good trading entry.
- Forums
- ASX - By Stock
- scoping study publication
NMR
native mineral resources holdings limited
Add to My Watchlist
0.00%
!
18.5¢

No perhaps in the scheme of it, isn't much. Having said that,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $169.8M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 18.5¢ | $118.3K | 613.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 119525 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 151030 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 119525 | 0.185 |
2 | 243550 | 0.180 |
4 | 182647 | 0.170 |
6 | 410121 | 0.165 |
7 | 301449 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 151030 | 2 |
0.195 | 23529 | 1 |
0.200 | 289771 | 4 |
0.210 | 200000 | 1 |
0.215 | 295988 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
NMR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online